(Â鶹ÒùÔºOrg.com) -- Scientists from the U.S. Department of Energy's Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide ...
The tubes that power X-ray machines are shrinking, improving the clarity and detail of their Superman-like vision. A team of nanomaterial scientists, medical physicists, and cancer biologists at the University of North Carolina ...
(Â鶹ÒùÔºOrg.com) -- Current radiation therapy treatment damages a patient's healthy tissue as well as eradicating the tumour it is intended to destroy, making the treatment especially invasive and often causing nasty side effects.
Dr. Esther Chang describes the most recent developments in human trials of the first systemic, non-viral, tumor-targeted, nanoparticle method designed to restore normal gene function to tumor cells while completely bypassing ...
A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the ...
(Â鶹ÒùÔºOrg.com) -- Biomaterial scientists in Manchester believe they have found a new way of isolating the ‘ingredients’ needed for potential stem cell treatments for nerve damage and heart disease.
Medical physicists at the University of Virginia have created a novel way to kill tumor cells using nanoparticles and light. The technique, devised by Wensha Yang, an instructor in radiation oncology at the University of ...
A new study identifies a signaling molecule that plays a major role in radiation-induced intestinal damage. The research, published by Cell Press in the June issue of the journal Cell Stem Cell, may lead to new strategies ...
With major implications for long-duration space travel, a study from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center demonstrates that the high-energy radiation found in space may lead to ...
Radioactive elements, or radionuclides, are well-established anticancer agents whose main limitation is that they kill healthy cells almost as easily as they do tumors. But because nanoparticles can be targeted to tumors, ...
